Searle Company Limited has officially denied rumors circulating on social media, especially WhatsApp, regarding its alleged interest in acquiring a 51% stake in Abbott Laboratories.
In an official clarification issued by the company, Searle categorically denied any discussions, negotiations or interest in acquiring the Abbott Laboratories stake.
“We refer to the recent news circulating on various media platforms (WhatsApp) alleging that Searle Company Limited has expressed interest in acquiring a 51% stake in Abbott Laboratories. We categorically deny this allegation and would like to clarify that no such discussions or negotiations have been initiated by the company.” or interests in connection with Abbott Laboratories or any acquisition of its interest,” Searle’s notice said.
The company advised the public and stakeholders to ignore unverified claims and rely only on official announcements issued through the Pakistan Stock Exchange (PSX) or other authorized communication channels.
Searle also stressed that in the event of any material developments, the company will disclose relevant information to PSX and the authorities in accordance with applicable laws and regulations.